Stock A126870 NEUROS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Neuros Co., Ltd.

Equities

A126870

KR7126870005

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Neuros Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Neuros Co., Ltd. Auditor Raises 'Going Concern' Doubt
CI
Neuros Co., Ltd. cancelled the transaction announced on January 11, 2021
CI
Neuros Co., Ltd. announced that it expects to receive KRW 17.734499685 billion in funding from HSD Shanghai Hosungde New Energy Technology Co., Ltd., HSD Korea Co., Ltd.
CI
Neuros Co., Ltd. announced that it has received KRW 10 billion in funding
CI
Neuros Co., Ltd. announced that it expects to receive KRW 10 billion in funding
CI
Neuros Co., Ltd. announced that it has received KRW 3.5 billion in funding
CI
Neuros Co., Ltd. announced that it expects to receive KRW 3.5 billion in funding
CI
Neuros Co., Ltd. announced that it has received KRW 8.5 billion in funding from NongHyup Bank, Investment Arm, Industrial Bank of Korea, Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Core Trend,Ltd
CI
Neuros Co., Ltd. announced that it expects to receive KRW 8.5 billion in funding from NongHyup Bank, Investment Arm, Industrial Bank of Korea, Investment Arm, NH Investment & Securities Co., Ltd., Investment Arm, Core Trend,Ltd, and another investor
CI
Neuros Co., Ltd. announced that it has received KRW 8.5 billion in funding from NH Investment & Securities Co., Ltd., Asset Management Arm, Shinhan Investment Corp., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, BFA Co.,Ltd., Korea Securities Finance Corporation, Investment Arm
CI
Neuros Co., Ltd. announced that it expects to receive KRW 8.5 billion in funding from NH Investment & Securities Co., Ltd., Asset Management Arm, Shinhan Investment Corp., Investment Arm, Samsung Securities Co. Ltd., Investment Arm, Korea Investment & Securities Co., Ltd., Investment Arm, BFA Co.,Ltd., Korea Securities Finance Corporation, Investment Arm
CI
Tranche Update on Neuros Co., Ltd.'s Equity Buyback Plan announced on April 5, 2016.
CI
Neuros Co., Ltd.’s Equity Buyback announced on April 5, 2016 has expired with 406,866 shares, representing 2.97% for KRW 2,004.37 million.
CI
Neuros Co., Ltd. announced that it has received KRW 20 billion in funding from Golden Bridge Asset Management Co., Ltd., Synergy Asset Management Co., Ltd.
CI
Neuros Co., Ltd. announced that it expects to receive KRW 20 billion in funding from Golden Bridge Asset Management Co., Ltd., Synergy Asset Management Co., Ltd.
CI
Neuros Co., Ltd.'s Equity Buyback Plan Extended till April 4, 2018.
CI
Hyundai Asset Management Co., Ltd. acquired a 6.9% stake in Neuros Co., Ltd..
CI
Neuros Co., Ltd. announced that it has received KRW 13 billion in funding from Hyundai Asset Management Co., Ltd., Shinhan Investment Corp., IBK Capital Corporation, Shinhan Capital Co., Ltd., KTB Asset Management Co., Ltd
CI
Neuros Co., Ltd. announced that it expects to receive KRW 13 billion in funding from Hyundai Asset Management Co., Ltd., Shinhan Investment Corp., IBK Capital Corporation, Shinhan Capital Co., Ltd., KTB Asset Management Co., Ltd
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A126870 Stock
  4. News Neuros Co., Ltd.